Nada Božina

7PUBLICATIONS
13CO-AUTHORS
Exploration geochemistryMolecular targetsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 20, 2023
Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.

Nada Božina, Ivana Šušak Sporiš, Iva Klarica Domjanović

|Jan 13, 2023
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand?

Lucija Lešnjaković, Lana Ganoci, Ivan Bilić

|Dec 23, 2022
SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism.

Gordana Nedic Erjavec, Mirko Grubor, Maja Zivkovic

|Mar 28, 2022
Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes.

Livija Šimičević, Iva Canjuga, Lada Zibar

|Oct 20, 2021
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.

Iveta Merćep, Ivana Radman, Vladimir Trkulja

|May 06, 2020
Severe hyperglycaemia following pazopanib treatment: The role of drug-drug-gene interactions in a patient with metastatic renal cell carcinoma-A case report.

Darija Kuruc Poje, Nada Božina, Livija Šimičević

Pageof 2

Frequent Collaborators

4 joint publications

Livija Šimičević

3 joint publications

Lana Ganoci

2 joint publications

Vladimir Trkulja

1 joint publications

Darija Kuruc Poje